METHOD FOR PRECLINICAL TESTING OF IMMUNOMODULATORY DRUGS

• 1. 临床前测试免疫调节药物的方法 [P] . 中国专利： CN102597768B . 2015.01.07
• 2. 临床前测试免疫调节药物的方法 [P] . 中国专利： CN102597768A . 2012-07-18
• 3. Method for preclinical testing of immunomodulatory drugs [P] . 欧洲知识产权局专利： EP2302380B2 . 2015-11-11

  机译： 免疫调节药物的临床前测试方法

• 4. METHOD FOR PRECLINICAL TESTING OF IMMUNOMODULATORY DRUGS [P] . IN2012CN02787A . 2013-05-17

  机译： 免疫调节药物的临床前测试方法

• 5. Method for preclinical testing of immunomodulatory drugs [P] . SI2302380T1 . 2013-04-30

  机译： 免疫调节药物的临床前测试方法

• 1. Threefold Increase in the Number of Drug Resistant TB Cases after Introduction of Universal Drug Susceptibility Testing: Experiences from Two South India Districts [J] . Sanath Kumar Gurram Krishnamurthy, Sharath Burugina Nagaraja, Tanu Anand, 结核病研究（英文） . 2020,第002期
• 2. Translational research in oncology: The need of additional in vitro preclinical testing methods for new drugs [J] . DrellIVT.L., Z?nkerK.S., EntschladenF. Current pharmaceutical design . 2012,第23期
• 3. Translational research in oncology: The need of additional in vitro preclinical testing methods for new drugs [J] . DrellIVT.L., Z?nkerK.S., EntschladenF. Current pharmaceutical design . 2012,第23期
• 4. Abuse liability assessment in preclinical drug development: Predictivity of a translational approach for abuse liability testing using methylphenidate in four standardized preclinical study models [J] . Teuns Greet B. A., Geys Helena M., Geuens Sonja M. A., Journal of Pharmacological and Toxicological Methods . 2014,第3期
• 5. Development of a tumour model for preclinical tests of targeted anticancer drug formulationsbased on Caco-2 cells grown on the chicken embryos chorioallantoic membrane (CAM) [C] . Brigitta Loretz, Ulrich F. Schaefer, Claus-Michael Lehr Annual meeting exposition of the Controlled Release Society . 2009
• 6. Safety and Efficacy of the Immunomodulatory Drug (IMiD) Lenalidomide in Patients with Lymphoma: Development of RU051417I - Phase I/II Open-Label Study of R-ICE (Rituximab-Ifosfamide-Carboplatin-Etoposide) with Lenalidomide [R2-ICE] in Patients with First-Relapse/Primary Refractory Diffuse Large B-Cell Lymphoma (DLBCL). [D] . Kasi, Pashtoon Murtaza. 2018
• 7. The immunomodulatory drugs lenalidomide and pomalidomide enhance the potency of AMG 701 in multiple myeloma preclinical models [O] . Shih-Feng Cho, Liang Lin, Lijie Xing, 2020
• 8. Preclinical evaluation of the immunomodulatory lymphocyte trafficking drug FTY720 for HIV prevention in the female genital mucosa of macaques [O] . Monica Morris, Rachael D. Aubert, Katherine Butler, 2014

• 1. Utility of a Relatively Affordable In-House HIV-1 Genotyping Assay for Drug Resistance Testing among Non B HIV-1 Infected Drug Naive Patients in Nigeria [J] . J. A. Anejo-Okopi ,H. Onywera ,I. O. Abah . 微生物学（英文） . 2018,第5期
• 2. A Comparative Study of Drug Susceptibility Testing Techniques for Identification of Drug Resistant TB in a Tertiary Care Centre, South India [J] . J. Anto Jesuraj Uday Kumar ,Hiresave Srinivasa ,Justy Antony Chiramal . 结核病研究（英文） . 2017,第1期
• 3. Drug-transporter interaction testing in drug discovery and development [J] . Peter Krajcsi . 世界药理学杂志 . 2013,第001期
• 4. Immunomodulatory Activities of a Concentrated Fruit and Vegetable Juice Tested in a Randomized,Placebo-Controlled,Double-Blind Clinical Trial in Healthy Volunteers [J] . Manfred Schmolz ,Reinhard W.Marz ,Marco Schaudt . 食品与营养科学（英文） . 2014,第4期
• 5. 溶瘤病毒类药物临床前评价的一般性考虑 [C] . 张素才 ,汪宁 ,孙云霞 . 2017年第七届药物毒理学年会 . 2017
• 6. 护士抗肿瘤药物、免疫抑制剂与免疫调节剂、血液及造血系统药物处方权内容的研究 [A] . 孟伊霏 . 2020